Growth Metrics

Sanara MedTech (SMTI) Net Income towards Common Stockholders (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Net Income towards Common Stockholders for 15 consecutive years, with -$31.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Income towards Common Stockholders fell 132615.77% year-over-year to -$31.2 million, compared with a TTM value of -$38.1 million through Sep 2025, down 579.11%, and an annual FY2024 reading of -$9.8 million, down 121.22% over the prior year.
  • Net Income towards Common Stockholders was -$31.2 million for Q3 2025 at Sanara MedTech, down from -$1.8 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $2.5 million in Q3 2022 and bottomed at -$31.2 million in Q3 2025.
  • Average Net Income towards Common Stockholders over 5 years is -$3.4 million, with a median of -$1.8 million recorded in 2025.
  • The sharpest move saw Net Income towards Common Stockholders skyrocketed 225.93% in 2022, then crashed 132615.77% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$3.5 million in 2021, then dropped by 18.6% to -$4.2 million in 2022, then surged by 93.76% to -$262444.0 in 2023, then plummeted by 534.05% to -$1.7 million in 2024, then plummeted by 1777.78% to -$31.2 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for SMTI at -$31.2 million in Q3 2025, -$1.8 million in Q2 2025, and -$3.4 million in Q1 2025.